Novartis cuts staff at Horhsam, UK site; creates jobs in China
Novartis, the Basel, Switzerland-based pharma giant, has announced a raft of job cuts at its research and development site in Horsham, UK.
Novartis, the Basel, Switzerland-based pharma giant, has announced a raft of job cuts at its research and development site in Horsham, UK.
Genzyme will be unable to meet demand for Thyrogen until July 2011 because of a manufacturing issue.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Cytel and Laureate Biopharmaceutical.
Contract services firm Almac aims to expand its trial patient management and compliance offering though a new partnership with ePRO specialist Exco InTouch.
Inovio has received a US grant to investigate delivering DNA vaccines to different parts of the body at the same time.
ShangPharma said it saw revenue climb on higher customer spending in the fourth quarter, but that margins slid due to currency effects and higher share-based compensation.
in-PharmaTechnologist presents a round-up of fine chemicals news, including developments at Camlin, CABB, Albemarle and Materia.
Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa.